Background-Reproductive factors provide an early window into a woman's coronary heart disease (CHD) risk; however, their contribution to CHD risk stratification is uncertain. 
H eart disease is the leading cause of mortality among women in the United States. 1 The importance of knowing whether a woman's risk of coronary heart disease (CHD) is low, medium, or high is important when considering when and how aggressively to modify her CHD risk factors. If we had an earlier window of detection into a woman's level of CHD risk, we would be better able to institute earlier lifestyle-change counseling and, when appropriate, pharmacotherapy to change risk factors such as hypertension or dyslipidemia.
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Several reproductive history factors in women have been individually associated with CHD, including number of pregnancies, 2,3 a lack of breastfeeding, 4 menstrual cycle irregularities, 5 pregnancy loss (ie, stillbirth and miscarriage), 6, 7 and a history of infertility/difficulty conceiving. 8 These reproductive history factors can be ascertained before the onset of traditional CHD risk factors and could potentially be used for earlier and more aggressive risk factor modification. However, it is uncertain which of these reproductive factors are significantly associated with CHD when considered together and whether they are independently related to CHD over and beyond established CHD risk factors.
Methods Study Sample: Women's Health Initiative Observational Study
The Women's Health Initiative (WHI) recruitment began in 1991 and consisted of a set of clinical trials and an observational study of hormone therapy, dietary modification, and calcium/vitamin D supplementation on cardiovascular disease, cancer, and fractures. We considered all women who participated in the WHI observational study, but not in the clinical trials, to avoid the effects of interventions on outcomes. Among all women in the WHI observational study (n=93 676), we excluded those with missing reproductive (n=13 155) and CHD risk factor information (n=4101), women without followup (n=476), and women with prevalent or unknown history of CHD (n=5902). After exclusions, our final sample size was n=72 982.
Ascertainment of Reproductive Exposures
Information on reproductive factors was collected via a questionnaire at the second screening visit in the WHI (between 1993 and 1998). Candidate reproductive risk factors for CHD included pregnancy status (ever/never had a pregnancy lasting at least 6 months), number of live births, age at menarche, menstrual irregularity (no [referent] , yes, sometimes regular and sometimes irregular), age at first birth (referent group, women giving birth at >25 years of age), number of stillbirths, number of miscarriages, any reported history of infertility ≥1 year (defined as trying to conceive unsuccessfully for ≥1 year whether or not this led to eventually becoming pregnant), the specific cause of the infertility (among women reporting this), having breastfed one's baby for at least 1 month (reporting ≥1 month of lifetime exposure of breastfeeding).
Ascertainment of Established CHD Risk Factors Values
Body mass index (BMI) was calculated using height and weight (kg/ m 2 ) measured by study staff at baseline. Systolic blood pressure was measured at the baseline examination and antihypertensive medications were recorded. Diabetes mellitus was identified by self-reported use of antidiabetic medications, and hyperlipidemia by self-reported use of cholesterol-lowering medications. Medication use was validated on enrollment by nurse examination of medication bottles. Physical activity was assessed by questionnaire as was self-reported family history of premature CHD (age <60 in any first-degree relative).
Ascertainment of CHD Outcomes
The primary outcome for our study was physician-adjudicated fatal and nonfatal CHD (including clinical myocardial infarction, CHD death, or coronary artery revascularization in the form of coronary artery bypass surgery or percutaneous coronary intervention). As of September 30, 2010 there were 4607 CHD events in our sample.
Statistical Analysis Plan
In our methodologic approach, we used several of American Heart Association consensus-recommended metrics to evaluate the utility of reproductive factors on CHD risk stratification. 9 In brief, these metrics were recommended as a means to assess the utility of novel biomarkers in CVD risk stratification. Specific metrics include assessing the independence of the risk markers over and beyond established risk factors, assessing the ability of the diagnostic test (or in this case a risk model) to increase the C statistic (which in this analysis we estimated based on survival times), and assessing the ability of the risk marker to accurately reclassify patients into higher-or lower-risk categories by taking into account observed versus expected events. Descriptive characteristics including numbers, means, and standard deviations are presented. We performed Kendall Tau correlations between the reproductive factors and established risk factors to anticipate potential model collinearity. We used multivariable Cox proportional hazards regression analysis for CHD outcomes. Follow-up time began at WHI study enrollment. To assess the utility of a reproductive history as a standalone test in women, assuming that, in many cases, it would be available in younger women before the onset of established risk factors, we first constructed a model with age and the candidate reproductive risk factors. Next, we assessed each reproductive factor in models with established CHD risk factors. In this step, we began with established CHD risk factors including age, diabetes mellitus, systolic blood pressure, hypertension medications, dyslipidemia, and smoking status and added each reproductive factor in separate models to determine whether the reproductive factor was independently related to CHD. If a reproductive factor was significantly related to CHD when considered with established CHD risk factors at an α of ≥0.1, then it was added to a final model with other significant reproductive factors plus established risk factors. The C statistic and its change, together with 95% confidence intervals for these models, were calculated.
The net-reclassification approach using a survival approach 10 was used to determine whether knowledge of the reproductive factors more accurately stratified women into CHD risk categories. 11 We constructed 2 different sets of CHD risk classes. First, we chose <5%, 5 to <10%, and ≥10% 10-year risk of CHD given that most women have relatively lower 10-year predicted CHD risks than men 12 and do generally fall in the <5 or <10% 10-year risk categories. 12, 13 Second, based on the recent CVD prevention guidelines, 14 we assessed dichotomous risk categories with the cut point of estimated CHD risk at 7.5%. In addition, we calculated an integrated discriminatory index that measures the improvement in the slope of model discrimination with the new marker (the integrated discriminatory index is useful when risk cut points are not available).
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In secondary models adjusting for established CHD risk factors, we explored dose-response relationships between the following reproductive factors and CHD: number of live births, number of stillbirths, number of miscarriages, and number of tubal pregnancies. In a secondary analysis aimed at assessing confounding of reproductive factor and CHD associations by socioeconomic status (SES), we added income, education, and a neighborhood/zipcode-based SES indicator 15 to age-adjusted reproductive factor CHD models. We explored models that contained BMI, physical activity index, and a family history of premature CHD (<60 years of age) 16 in addition to reproductive and established risk factors given that these are common clinically measured risk factors that have traditionally aided clinicians in CHD risk stratification of patients. All analyses were conducted in SAS version 9.3 and R version 2.15. The study was approved by an institutional review committee at the University of California San Francisco, and the subjects gave informed consent. Table I in the online-only Data Supplement summarizes the models of each reproductive factor added to established CHD risk factors. From these models, the following reproductive variables were related to CHD (at a P value of ≤0.1) and thus considered in the next model: menstrual irregularity, ever pregnant, number of live births, age at first birth, stillbirths, miscarriages, and having breastfed one's baby for at least 1 month. When considered together with established CHD risk factors, the following reproductive factors remained significantly related to CHD (at a P value of <0.05): age at first birth, stillbirths, miscarriages, and having breastfed one's baby for at least 1 month (protective for CHD; Table 2 ).
Results
Models of Reproductive Risk Factors Added to Established Risk Factors
Model Discrimination
The age-adjusted reproductive risk model had a C statistic of 0.675, whereas the established CHD risk factor model had a C statistic of 0.726 (Table 3) . Table 3 demonstrates the change in CHD discrimination/C statistic for the established CHD risk factor model with the addition of each individual reproductive risk factor. When significant reproductive risk factors (age at first birth, number of stillbirths, number of miscarriages, breastfed one's baby for at least 1 month) were all added to the established CHD risk factor model, the C statistic changed from 0.726 to 0.730 (mean increase, 0.0033; Bootstrap 95% CI, 0.0022-0.0051; Table 3 ). Tables 4 and 5 demonstrate the net reclassification of women with low (<5%), medium (5 to ≤10%), and high (>10%) risk of CHD as predicted by the established risk factor model alone and with the addition of the pregnancy factors. Thirtyone percent of women who developed CHD events were in the low-risk group, 39% were in the intermediate-risk group, and 30% were in the high-risk group (as classified by the established CHD plus significant reproductive risk factors model).
Net Reclassification of CHD
Of women who experienced CHD events, 6.8% were correctly reclassified to a higher-risk category in comparison with 6.1% of women incorrectly reclassified to a lower-risk category (net reclassification index events, 0.007; P=0.18). Sixty-one percent of women not experiencing events were in a low-risk group, 27% were in a medium-risk group, and 12% were in a high-risk group among women not experiencing events (as classified by the established CHD plus significant reproductive risk factors model). Among women not experiencing a CHD event, 4.3% were correctly reclassified to a lower-risk group in comparison with 4.5% of women incorrectly reclassified to a higher-risk group (net reclassification index nonevents, 0.002; P=0.04). Next, we analyzed net reclassification by using dichotomous categories of <7.5% and ≥7.5%. Fifty-three percent of women who experienced a CHD event were classified as low risk, and 47% were classified as high risk by using this cut point (as classified by the established CHD plus significant reproductive risk factors model). Among women experiencing a CHD event, 3.9% were correctly reclassified from low to high risk versus 3.0% were incorrectly reclassified from high to low risk (net reclassification index events, 0.009; P=0.02). Seventy-nine percent of women not experiencing an event were classified as low risk and 21% were classified as high risk (as classified by the established CHD plus significant reproductive risk factors model). Among women who did not experience a CHD event, 2.0% of women were correctly reclassified from high to low risk and 2.2% of women were incorrectly reclassified from low to high risk (net reclassification index nonevents, 0.002; P=0.02).
Integrated Discrimination Improvement
The integrated discrimination improvement of reproductive factors added to established CHD risk factors model yielded 
Secondary Analyses
Assessment of Dose-Response Relationships of Selected Reproductive Factors and CHD
When considered in separate models adjusting for established CHD risk factors, the number of live-birth categories was positively associated with CHD in a dose-response relationship (HR, 1.03; 95% CI, 1.01-1.06; P trend=0.02). An increasing number of stillbirths was associated with CHD (HR, 1.14; 95% CI, 1.06-1.22; P trend=0.0003). Similarly, the number of miscarriages and CHD demonstrated a dose-response relationship (HR, 1.10; 95% CI, 1.07-1.14; P trend<0.0001). In addition, the number of tubal pregnancies was associated with CHD in a dose-response fashion (HR, 1.09; 95% CI. 1.004-1.18; P trend=0.04).
Exploration of SES on Relationship Between Reproductive Factors and CHD
After adding income, education, and a census tract/zipcode-based neighborhood SES indicator variables to the 
Accounting for Other CHD Clinical Risk Predictors
After addition of BMI, physical activity index, and family history of premature CHD to models containing reproductive risk factors and established risk factors, results were not materially changed (Table II in the online-only Data Supplement).
Discussion
Summary of Main Findings
Among postmenopausal women, the following reproductive factors were related to CHD in age-adjusted models: early at first birth, stillbirths, miscarriages, irregular menses, and breastfeeding for ≥1 month. An age-adjusted model including these reproductive factors yielded CHD model discrimination of 0.675. In models of reproductive factors added to established CHD risk factors, all of the same reproductive factors, with the exception of irregular menses, were independently associated with CHD risk and very modestly increased model discrimination over and beyond established CHD risk factors (C statistic increased from 0.726 to 7.30).
Further adjustment for SES attenuated but did not fully account for the associations between reproductive factors and CHD. Reproductive factors did not materially improve overall CHD net reclassification over and beyond established CHD risk factors.
Potential Mechanisms and Previous Studies Linking Reproductive Risk Factors and CHD
In an earlier investigation of reproductive effects and CHD in the Nurse's Health Study, investigators did not demonstrate significant associations between parity, age at first birth, or age at menarche and coronary heart disease. 17 Although the sample size in this study was larger than in our current study (n=119 963 versus 72 982), the follow-up time and number of events was substantially smaller (number of events in previous study, 308 versus 4607), 17 which likely accounted for similar event sizes but lack of statistical significance in the previous analysis.
Consistent with our findings, a previous investigation in the WHI has also demonstrated that a longer duration of infant breastfeeding is associated with decreased development of maternal hypertension, diabetes mellitus, hyperlipidemia, and CVD. 18 Breastfeeding practices are modifiable and thus may represent a potential target for intervention to reduce later CHD risk in women.
Pregnancy in adolescence can disrupt a still growing female's cardiometabolic health and, in turn, can lead to greater postpartum maternal weight retention in comparison with having a pregnancy in adulthood. 19 Having a history of a previous term pregnancy at an age <20 years is associated with adverse effects on cardiometabolic profile in women, 20 including lipid profile, 21 increased blood pressure, 20 and greater adiposity. 19 Consistent with these previous investigations, we demonstrate that early pregnancy is related to CHD on accounting for both established CHD risk factors and other reproductive factors in WHI. Our secondary analysis suggests that SES does not fully account for the association between age at first birth and later 
Circulation
May 31, 2016
CHD in women. However, a previous investigation from the United Kingdom did suggest that social and behavioral factors accounted for the association between an early age at first pregnancy and most cardiometabolic risk factors (with the exception of high blood pressure) in adulthood in both men and women. 20 Therefore, it is still possible that income, education, and neighborhood/zipcode-based SES do not fully account for socioeconomic differences in WHI.
In WHI, pregnancy loss has been previously related to increased cardiovascular events. 7 It is estimated that 10% of stillbirths are attributable to maternal factors, including hypertension, diabetes mellitus, smoking, and obesity. 22, 23 Indeed our findings demonstrated that history of stillbirth and miscarriages 24 were associated with incident CHD, independent of established risk factors, other reproductive/pregnancy risk factors, and SES.
Early age at menarche is more common among girls with a high BMI and, in turn, is associated with a higher BMI later in life. 25, 26 Early menarche has been reported to be associated with later life increases in insulin resistance, 27 metabolic syndrome, 27 systolic blood pressure, 25 and dyslipidemia 25 ; recently, age at menarche was found to have a U-shaped relationship with CVD in a large UK cohort. 28 However, we did not demonstrate that age at menarche is independently associated with increased CHD, after accounting for other reproductive factors and established risk factors.
Menstrual irregularity, a proxy for polycystic ovarian syndrome, has been associated with incident CVD 29 and CVD mortality 5 (although, in the latter study, not independent of body mass index). 5 In our study, we found that the association between menstrual irregularity and CHD was likely mediated through established CHD risk factors. The difference between our study and a previous investigation 29 may be because of the fact that our study accounted both for other reproductive factors and hypertension, hypercholesterolemia, and diabetes mellitus, as well.
Using Reproductive Risk Factors in CHD Risk Stratification
Taken as a whole, our analyses indicate that key reproductive risk factors are independently associated with CHD but do not materially add to traditional risk prediction in postmenopausal women. In terms of comparison with traditional risk scores such as the 10-year Framingham Risk Score for CHD 30 (risk factors: age, sex, total cholesterol, high-density lipoprotein cholesterol, systolic blood pressure, hypertension medications, and smoking), we did not account for serum levels of total or high-density lipoprotein cholesterol. We did include use of cholesterol medications and diabetes mellitus. Diabetes mellitus is indeed included in the more recent 2013 American College of Cardiology/American Heart Association Guideline on the Assessment of Cardiovascular Risk (or atherosclerotic cardiovascular disease risk score). 14 Our data suggest that reproductive information may be the most useful in premenopausal women, and possibly before the development of traditional risk factors such as hypertension, diabetes mellitus, and dyslipidemia. In particular, the model discrimination of 0.675 for the age-reproductive factor model demonstrated in our study, although lower than major CHD risk prediction scores (that have C statistics in the range of 0.75-0.80 16, 31, 32 ), is very similar to that of other widely used clinical risk scores such as the CHADS2-VASC 33 for stroke risk stratification and anticoagulation decision making in atrial fibrillation. 34 Among younger women, reproductive factors often precede the onset of established CHD risk factors and could thus guide risk factor modification. Furthermore, the reproductive risk factors are based solely on a medical history or on medical chart review, and therefore constitute a simple, noninvasive, and inexpensive risk stratification tool. Thus, their use in CHD risk stratification, either alone or in concert with established factors, may enhance our ability to risk stratify young women in a simple and cost-effective way.
It is important highlight that our study only ascertained postmenopausal CHD events and that we did not have adjudicated premenopausal events, which may be even more strongly related to reproductive factors than postmenopausal CHD. Future studies should focus on better elucidating the association between reproductive factors and premenopausal or early CHD and the ability of reproductive factors to add to risk stratification in women at younger ages.
Strengths and Limitations
The WHI represents a unique and rare source of longitudinal data on reproductive/pregnancy factors, CHD risk factors, and CHD. Measures were carefully standardized and CHD outcomes were rigorously assessed. Although one of the primary aims of the WHI study was to assess the effects of hormone replacement therapy on CVD outcomes, we performed our analysis in the observational study and not in the hormone therapy clinical trial. There are several limitations that should be emphasized. Our findings demonstrating associations between reproductive factors and incident CHD were modest in effect size. Also, information on preeclampsia/pregnancyinduced hypertension, gestational diabetes, gestational age, and infant birth weight and size, which have been related to CHD in previous studies, [35] [36] [37] [38] and which would have been relevant to include in the current study, unfortunately were not available in WHI. Because of the constraints of enrollment in WHI we considered the start of follow-up time at study enrollment/perimenopause and not at the time of pregnancy, which would have been the most desirable approach. Thus, premenopausal CHD events were not adjudicated, so we could not assess the association between reproductive factors and premenopausal CHD. We could not account for prepregnancy risk factors in this study. Furthermore, we did not account for hormone therapy because this is not routinely done in most CVD risk stratification models. Systolic blood pressure was directly measured; however, dyslipidemia and diabetes mellitus were assessed by self-report and use of medications. We did not perform validation of our model on a separate cohort. Selection of variables was performed, and, therefore, our effect sizes are likely overestimated.
Conclusions
When considered together, early age at first birth, number of stillbirths and miscarriages, and lack of breastfeeding for ≥1 month are independently associated with postmenopausal CHD and very modestly improve postmenopausal CHD event discrimination over and beyond established risk factors. Net
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reclassification of CHD is not materially improved by the addition of reproductive factors to established risk factors. Our findings highlight the need for future studies relating reproductive factors to early/premenopausal CHD in women and a need for studies inclusive of additional validated pregnancy complications such as gestational diabetes mellitus, preeclampsia, gestational age, and infant size that have even stronger demonstrated associations with maternal CHD than reproductive factors, and therefore may also serve as useful primordial and primary CHD prevention risk markers.
